Picture of Veru logo

VERU Veru Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Annual income statement for Veru, fiscal year end - September 30th, USD millions except per share, conversion factor applied.

2021
September 30th
2022
September 30th
2023
September 30th
R2024
September 30th
2025
September 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K/A10-K/A10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue61.339.416.300
Cost of Revenue
Gross Profit47.930.67.57
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses48.312311036.216.1
Operating Profit13-83.5-93.8-36.2-16.1
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes4.27-83.8-92.7-35.3-15.7
Provision for Income Taxes
Net Income After Taxes7.39-84-93.2-35.3-15.7
Net Income Before Extraordinary Items
Extraordinary Items
Net Income7.39-84-93.2-37.8-22.7
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income7.39-84-93.2-37.8-22.7
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-0.546-10.5-11.1-2.7-2.4